Larimar Therapeutics, Inc.LRMRNASDAQ
Loading
Other Income/Expenses (Net) Over TimeContracting
Percentile Rank93
3Y CAGR+80.0%
5Y CAGR+84.2%
Studio
Year-over-Year Change

Net other income and expenses outside core operations

3Y CAGR
+80.0%/yr
Annual compound
5Y CAGR
+84.2%/yr
Recent deceleration
Percentile
P93
Near historical high
vs 5Y Ago
21.2x
Strong expansion
Streak
1 yr
Consecutive declineContracting
PeriodValueYoY Change
TTM$6.82M-33.7%
2024$10.29M+113.9%
2023$4.81M+310.7%
2022$1.17M+784.8%
2021$-171000.00-153.1%
2020$322000.00+292.7%
2019$82000.00+133.3%
2018$-246000.00-126.0%
2017$947000.00+189.7%
2016$-1.06M-